We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Aims to Reduce Confusion in Drug Risk Communication
FDA Aims to Reduce Confusion in Drug Risk Communication
February 17, 2006
The FDA will issue guidance clarifying when the agency would use its proposed Drug Watch website to present drug safety information because of concerns about confusion regarding the number of different information outlets.